Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-03-15

Clinical Trial Update: Prophylactic Oxytocin Before Versus After Placental Delivery to Reduce Blood Loss in Vaginal Delivery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether administering oxytocin before placental delivery reduces blood loss compared with administration after delivery during…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Ain Shams Maternity Hospital | Conditions: Postpartum Hemorrhage | Phase 2 | Status: UNKNOWN